Literature DB >> 8689905

Efficacy of metronidazole lavage in treatment of intraperitoneal sepsis. A prospective study.

S K Saha1.   

Abstract

In a prospective study, 182 consecutive patients were included for the treatment of intraabdominal sepsis with adjuvant metronidazole lavage that was carried out at the end of the operative procedures. Eighty of them underwent emergency surgery for peritonitis and 102 elective surgery for a variety of lesions. Although fecal peritonitis was found in 23 and malignant tumors in 84 patients, there was not a single instance of intraabdominal abscess in 182 patients, but the incidence of wound infection was 2.66% in the emergency group and 0% in the elective group; mortality was 5% and 3.9%, respectively. Therefore, adjuvant metronidazole lavage provides confidence in the treatment of intraperitoneal abscess, and it enhances a quick recovery. It is safe to use and cost effective.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8689905     DOI: 10.1007/bf02088553

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  27 in total

1.  Comparison of two prophylactic single-dose intravenous antibiotic regimes in the treatment of patients undergoing elective colorectal surgery in a district general hospital.

Authors:  R D Kingston; R S Kiff; J S Duthie; S Walsh; A Spicer; J Jeacock
Journal:  J R Coll Surg Edinb       Date:  1989-08

2.  Single-dose antibiotic prophylaxis of abdominal surgical wound infection: a trial of preoperative latamoxef against peroperative tetracycline lavage.

Authors:  P Sauven; M J Playforth; G M Smith; M Evans; A V Pollock
Journal:  J R Soc Med       Date:  1986-03       Impact factor: 5.344

3.  The use of continuous postoperative peritoneal lavage in the management of diffuse peritonitis.

Authors:  J P McKenna; D J Currie; J A MacDonald; L J Mahoney; D C Finlayson; J C Lanskail
Journal:  Surg Gynecol Obstet       Date:  1970-02

4.  Peritoneal lavage with metronidazole.

Authors:  S K Saha
Journal:  Surg Gynecol Obstet       Date:  1985-04

5.  Double-blind comparison of metronidazole plus gentamicin and clindamycin plus gentamicin in intra-abdominal infection.

Authors:  J R Kirkpatrick; B J Anderson; J J Louie; H G Stiver
Journal:  Surgery       Date:  1983-01       Impact factor: 3.982

6.  A clinical evaluation of postoperative peritoneal lavage in the treatment of perforated appendicitis.

Authors:  P Udén; P Eskilsson; L Brunes; T Mätzsch
Journal:  Br J Surg       Date:  1983-06       Impact factor: 6.939

7.  Prospective comparative study of cefotetan with piperacillin for prophylaxis against infection in elective colorectal surgery.

Authors:  M J Hershman; R I Swift; D T Reilly; W A Logan; J M Sackier; H Gompertz; J Horner; N W Baker; C B Wood
Journal:  J R Coll Surg Edinb       Date:  1990-02

8.  Physical status is the principal determinant of outcome after emergency admission of patients with colorectal cancer.

Authors:  R D Kingston; S H Walsh; J Jeacock
Journal:  Ann R Coll Surg Engl       Date:  1993-09       Impact factor: 1.891

9.  Antibiotic treatment for surgical peritonitis.

Authors:  D M Mosdell; D M Morris; A Voltura; D E Pitcher; M W Twiest; R L Milne; B G Miscall; D E Fry
Journal:  Ann Surg       Date:  1991-11       Impact factor: 12.969

10.  Perioperative blood transfusion associated with infectious complications after colorectal cancer operations.

Authors:  P I Tartter; S Quintero; D M Barron
Journal:  Am J Surg       Date:  1986-11       Impact factor: 2.565

View more
  2 in total

Review 1.  [Relaparotomy in secondary peritonitis Planned relaparotomy or relaparotomy on demand?].

Authors:  B Lamme; C W Mahler; J W O van Till; O van Ruler; D J Gouma; M A Boermeester
Journal:  Chirurg       Date:  2005-09       Impact factor: 0.955

2.  Irrigation of abdomen with imipenem solution decreases surgical site infections in patients with perforated appendicitis: a randomized clinical trial.

Authors:  Mohammad Ali Hesami; Hamid Alipour; Hamed Nikoupour Daylami; Bijan Alipour; Shahrzad Bazargan-Hejazi; Alireza Ahmadi
Journal:  Iran Red Crescent Med J       Date:  2014-04-05       Impact factor: 0.611

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.